Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
XYF-13 by Xi'An Yufan Biotechnology for Recurrent Glioblastoma Multiforme (GBM): Likelihood of Approval
XYF-13 is under clinical development by Xi'An Yufan Biotechnology and currently in Phase II for Recurrent Glioblastoma Multiforme (GBM). According...
Gene Therapy to Target CD19 for Leukemia or Lymphoma by Xi'An Yufan Biotechnology for Marginal Zone B-cell Lymphoma: Likelihood of Approval
Gene Therapy to Target CD19 for Leukemia or Lymphoma is under clinical development by Xi'An Yufan Biotechnology and currently in...
Gene Therapy to Target CD19 for Leukemia or Lymphoma by Xi'An Yufan Biotechnology for Hairy Cell Leukemia: Likelihood of Approval
Gene Therapy to Target CD19 for Leukemia or Lymphoma is under clinical development by Xi'An Yufan Biotechnology and currently in...
Gene Therapy to Target CD19 for Leukemia or Lymphoma by Xi'An Yufan Biotechnology for Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma): Likelihood of Approval
Gene Therapy to Target CD19 for Leukemia or Lymphoma is under clinical development by Xi'An Yufan Biotechnology and currently in...
Gene Therapy to Target CD19 for Leukemia or Lymphoma by Xi'An Yufan Biotechnology for Follicular Lymphoma: Likelihood of Approval
Gene Therapy to Target CD19 for Leukemia or Lymphoma is under clinical development by Xi'An Yufan Biotechnology and currently in...
Gene Therapy to Target CD19 for Leukemia or Lymphoma by Xi'An Yufan Biotechnology for Burkitt Lymphoma: Likelihood of Approval
Gene Therapy to Target CD19 for Leukemia or Lymphoma is under clinical development by Xi'An Yufan Biotechnology and currently in...
Gene Therapy to Target CD19 for Leukemia or Lymphoma by Xi'An Yufan Biotechnology for Mantle Cell Lymphoma: Likelihood of Approval
Gene Therapy to Target CD19 for Leukemia or Lymphoma is under clinical development by Xi'An Yufan Biotechnology and currently in...
Gene Therapy to Target CD19 for Leukemia or Lymphoma by Xi'An Yufan Biotechnology for Diffuse Large B-Cell Lymphoma: Likelihood of Approval
Gene Therapy to Target CD19 for Leukemia or Lymphoma is under clinical development by Xi'An Yufan Biotechnology and currently in...
Gene Therapy to Target CD19 for Leukemia or Lymphoma by Xi'An Yufan Biotechnology for Chronic Lymphocytic Leukemia (CLL): Likelihood of Approval
Gene Therapy to Target CD19 for Leukemia or Lymphoma is under clinical development by Xi'An Yufan Biotechnology and currently in...
Gene Therapy to Target CD19 for Leukemia or Lymphoma by Xi'An Yufan Biotechnology for Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia): Likelihood of Approval
Gene Therapy to Target CD19 for Leukemia or Lymphoma is under clinical development by Xi'An Yufan Biotechnology and currently in...